Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

The Impact of Local Intervention Combined with Targeted Therapy on Metastatic Renal Cell Carcinoma

JIAN-RI LI, YEN-CHUAN OU, CHENG-KUANG YANG, SHIAN-SHIANG WANG, CHUAN-SU CHEN, HAO-CHUNG HO, CHEN-LI CHENG, CHI-REI YANG, CHENG-CHE CHEN, SHU-CHI WANG, CHIA-YEN LIN, SHENG-CHUN HUNG, CHIANN-YI HSU and KUN-YUAN CHIU
Anticancer Research September 2018, 38 (9) 5339-5345; DOI: https://doi.org/10.21873/anticanres.12861
JIAN-RI LI
1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
2Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.
3Department of Medicine and Nursing, Hung Kuang University, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YEN-CHUAN OU
4Tung's Taichung Metro Harbor Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHENG-KUANG YANG
1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHIAN-SHIANG WANG
1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
2Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.
5Department of Applied Chemistry, National Chi Nan University, Nantou, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHUAN-SU CHEN
1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
2Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HAO-CHUNG HO
1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHEN-LI CHENG
1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
2Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHI-REI YANG
6Department of Urology, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHENG-CHE CHEN
1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHU-CHI WANG
1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIA-YEN LIN
1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHENG-CHUN HUNG
1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIANN-YI HSU
7Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KUN-YUAN CHIU
1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
5Department of Applied Chemistry, National Chi Nan University, Nantou, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: chiu3778@yahoo.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Overall survival comparison among the complete focal disease control group, incomplete focal disease control group and targeted therapy-only group.

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
PreviousNext
Back to top

In this issue

Anticancer Research: 38 (9)
Anticancer Research
Vol. 38, Issue 9
September 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Impact of Local Intervention Combined with Targeted Therapy on Metastatic Renal Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
The Impact of Local Intervention Combined with Targeted Therapy on Metastatic Renal Cell Carcinoma
JIAN-RI LI, YEN-CHUAN OU, CHENG-KUANG YANG, SHIAN-SHIANG WANG, CHUAN-SU CHEN, HAO-CHUNG HO, CHEN-LI CHENG, CHI-REI YANG, CHENG-CHE CHEN, SHU-CHI WANG, CHIA-YEN LIN, SHENG-CHUN HUNG, CHIANN-YI HSU, KUN-YUAN CHIU
Anticancer Research Sep 2018, 38 (9) 5339-5345; DOI: 10.21873/anticanres.12861

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
The Impact of Local Intervention Combined with Targeted Therapy on Metastatic Renal Cell Carcinoma
JIAN-RI LI, YEN-CHUAN OU, CHENG-KUANG YANG, SHIAN-SHIANG WANG, CHUAN-SU CHEN, HAO-CHUNG HO, CHEN-LI CHENG, CHI-REI YANG, CHENG-CHE CHEN, SHU-CHI WANG, CHIA-YEN LIN, SHENG-CHUN HUNG, CHIANN-YI HSU, KUN-YUAN CHIU
Anticancer Research Sep 2018, 38 (9) 5339-5345; DOI: 10.21873/anticanres.12861
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients
  • Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study
  • Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer
Show more Clinical Studies

Similar Articles

Keywords

  • Local intervention
  • metastasectomy
  • Metastatic renal cell carcinoma
  • targeted therapy
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire